Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Celldex Therapeutics (CLDX) Return on Invested Capital (2018 - 2021)

Celldex Therapeutics (CLDX) has 3 years of Return on Invested Capital data on record, last reported at 0.04% in Q4 2021.

  • For Q4 2021, Return on Invested Capital rose 26.0% year-over-year to 0.04%; the TTM value through Dec 2021 reached 0.04%, up 26.0%, while the annual FY2021 figure was 0.05%, 36.0% up from the prior year.
  • Return on Invested Capital reached 0.04% in Q4 2021 per CLDX's latest filing, up from 0.29% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.04% in Q4 2021 and bottomed at 1.23% in Q4 2018.
  • Average Return on Invested Capital over 3 years is 0.54%, with a median of 0.45% recorded in 2018.
  • The widest YoY moves for Return on Invested Capital: up 26bps in 2021, down 26bps in 2021.
  • A 3-year view of Return on Invested Capital shows it stood at 1.23% in 2018, then soared by 76bps to 0.29% in 2020, then soared by 88bps to 0.04% in 2021.
  • Per Business Quant database, its latest 3 readings for Return on Invested Capital were 0.04% in Q4 2021, 0.29% in Q4 2020, and 0.3% in Q2 2020.